469 Treffer:
51.
A Phase 1b/2 Open-Label Study of Disitamab Vedotin Monotherapy or in Combination With Other Anticancer Therapies in Solid Tumors
NCT Heidelberg » Ihre Suche
Datum: 2025-10-23
52.
Comprehensive assessment of clinical features and biomarkers to identify patients with advanced or metastatic breast cancer for marker driven trials in humans (CATCH).
NCT Heidelberg » Ihre Suche
Datum: 2025-10-23
53.
Comprehensive assesment of clinical features, genomics and further molecular marker to identify patients with early breast cancer for enrolment on marker driven trials
NCT Heidelberg » Ihre Suche
Datum: 2025-10-23
54.
CAPTOR-BC: Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients
NCT Heidelberg » Ihre Suche
Datum: 2025-10-23
55.
A Randomized, Open-label, Phase II Trial Comparing Neoadjuvant Endocrine Therapy in Combination With Trastuzumab, Pertuzumab +/- the PI3K Inhibitor Inavolisib in Patients With HER2-positive, HR-positive, PIK3CA Mutant Early Breast Cancer-GeparPiPPa
NCT Heidelberg » Ihre Suche
Datum: 2025-10-23
56.
A Phase 1/1b/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 193 Alone and in Combination With Docetaxel in Subjects With Advanced MTAP-null Solid Tumors *Nur für NSCLS offen*
NCT Heidelberg » Ihre Suche
Datum: 2025-10-23
57.
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Global Study of Rilvegostomig in Combination With Chemotherapy as Adjuvant Treatment After Resection of Biliary Tract Cancer With Curative Intent (ARTEMIDE-Biliary01)
NCT Heidelberg » Ihre Suche
Datum: 2025-10-23
58.
Is CT 01 safe to use alone or combined with Everolimus for inoperable advanced liver cancer?
NCT Heidelberg » Ihre Suche
Datum: 2025-10-23
59.
deCOMPressing stomA and two-Stage elective resection vs. emergency reSection in patients with left-sided obstructive colon cancer
NCT Heidelberg » Ihre Suche
Datum: 2025-10-23
60.
A Phase 3, Multicenter, Open-label, Randomized Study to Compare the Efficacy and Safety of MK-2870 Versus Treatment of Physician's Choice in 3L+ Advanced/Metastatic Gastroesophageal Adenocarcinoma (Gastric Adenocarcinoma, Gastroesophageal Junction Adenoca
NCT Heidelberg » Ihre Suche
Datum: 2025-10-23